This article reviews medications commonly used for the treatment of patients with functional gastrointestinal disorders. Specifically, we review the animal models that have been validated for the study of drug effects on sensation and motility; the preclinical pharmacology, pharmacokinetics, and toxicology usually required for introduction of new drugs; the biomarkers that are validated for studies of sensation and motility end points with experimental medications in humans; the pharmacogenomics applied to these medications and their relevance to the FGIDs; and the pharmacology of agents that are applied or have potential for the treatment of FGIDs, including psychopharmacologic drugs.
Camilleri, M., Buéno, L., Andresen, V., DE PONTI, F., Choi, M.G., Lembo, A. (2016). Pharmacologic, pharmacokinetic, and pharmacogenomic aspects of functional gastrointestinal disorders. GASTROENTEROLOGY, 150(6), 1319-1331e20 [10.1053/j.gastro.2016.02.029].
Pharmacologic, pharmacokinetic, and pharmacogenomic aspects of functional gastrointestinal disorders
DE PONTI, FABRIZIO;
2016
Abstract
This article reviews medications commonly used for the treatment of patients with functional gastrointestinal disorders. Specifically, we review the animal models that have been validated for the study of drug effects on sensation and motility; the preclinical pharmacology, pharmacokinetics, and toxicology usually required for introduction of new drugs; the biomarkers that are validated for studies of sensation and motility end points with experimental medications in humans; the pharmacogenomics applied to these medications and their relevance to the FGIDs; and the pharmacology of agents that are applied or have potential for the treatment of FGIDs, including psychopharmacologic drugs.I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
